The Drug Eluting Stents Center

Filter Your Results

 

News

 

Refining Strategies for the SFA

With Krishna Rocha-Singh, MD, FACC, FAHA, FSCAI, FSVM; Peter A. Schneider, MD; Gunnar Tepe, MD; and Professor Thomas Zeller, MD

March 2014—A panel of experts discusses the promise of drug-eluting balloons and other techniques for treating SFA and popliteal lesions.

Alvimedica Launches Cre8 BTK Drug-Eluting Stent in Europe

April 7, 2014 -- Alvimedica Medical Technologies (Catalca, Turkey) announced the launch of the Cre8 BTK drug-eluting stent (DES), a polymer-free device for the treatment of be…

Twelve-Month Results of Zilver PTX in Long Femoropopliteal Lesions Presented at LINC

January 29, 2014 -- At LINC 2014: The Leipzig Interventional Course in Leipzig, Germany, Prof. Thomas Zeller, MD, presented the 12-month results of a postmarket study eva…

Cook Medical Presents 4-Year Primary Patency Data for Zilver PTX

October 8, 2013 -- Cook Medical (Bloomington, IN) announced that 4-year data from the Zilver PTX randomized controlled trial were presented at the VIVA 2013: Vascular Interven…

Understanding Iliac and Femoropopliteal Artery Restenosis

Satinder Singh, MD; Ehrin J. Armstrong, MD; and John R. Laird, MD

August 2013—Mechanisms, incidence, treatment, and outcomes of in-stent restenosis in the iliac and femoropopliteal arteries.

Cook’s Zilver PTX Returns to Market and Gains Additional CMS Reimbursement

August 7, 2013 -- Cook Medical (Indianapolis, IN) has resumed shipment of its Zilver PTX paclitaxel-eluting peripheral stent after addressing a delivery catheter issue that le…

Drug-Eluting Therapies for Infrapopliteal Lesions in Patients With CLI

Jihad A. Mustapha, MD, and Larry J. Diaz-Sandoval, MD

May 2013—Where do they stand, and where are they heading?

Cook Medical Initiates Voluntary Recall of Zilver PTX Due to Potential for Delivery System Catheter Separation

April 24, 2013 -- Cook Medical (Bloomington, IN) announced that the company has initiated a nationwide/global voluntary recall of its Zilver PTX drug-eluting peripheral stent.…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.